Results 151 to 160 of about 42,901 (212)

Severe Chemoradiotherapy Toxicity in a Pediatric Patient with Leigh Syndrome and Grade IV Isocitrate Dehydrogenase-Mutant Astrocytoma: A Case Report. [PDF]

Am J Case Rep
Granberry MT, Severance T, Biedermann G, Quinsey C, Mazuru DG, Bach A.   +5 more
europepmc   +1 more source

Studies on the Mechanism of Action of Isocitric Dehydrogenase

Journal of Biological Chemistry, 1960
openaire   +2 more sources

Correction to "Isocitrate Dehydrogenase 2 Mutation Promotes Cytarabine Resistance in Acute Myeloid Leukemia by Warburg Effect". [PDF]

Hematol Oncol
europepmc   +1 more source

Improvement of magnetic resonance imaging diffusion metric 'slow diffusion coefficient (SDC)' over apparent diffusion coefficient (ADC) for isocitrate dehydrogenase (IDH) genotyping in diffuse gliomas. [PDF]

Quant Imaging Med Surg
Zheng WY, Shi YT, He YY, Lin RL, Xiao BH, Jiang RF, Wáng YXJ.   +6 more
europepmc   +1 more source

Transcriptomic Profile of Isocitrate Dehydrogenase Mutant Type of Lower-Grade Glioma Reveals Molecular Changes for Prognosis. [PDF]

Biomedicines
Cho SB.
europepmc   +1 more source

A novel MRI diffusion metric 'slow diffusion coefficient' (SDC) for diagnosing isocitrate dehydrogenase (IDH) genotype in diffuse gliomas: initial promising results. [PDF]

BMC Med Imaging
Zheng WY, Shi YT, He YY, Lin RL, Xiao BH, Jiang RF, Wáng YXJ.   +6 more
europepmc   +1 more source

Assessing the predictability of isocitrate dehydrogenase mutational status in glioma patients using imaging features. [PDF]

Surg Neurol Int
Goncalves JM, Miranda A, Silva C, Carvalho B, Polónia P, Linhares P.   +5 more
europepmc   +1 more source

Characteristics of [¹⁸F]FET PET and MRI in isocitrate dehydrogenase (IDH)-mutant gliomas diagnosed according to the WHO 2021 classification - a retrospective analysis. [PDF]

Eur J Nucl Med Mol Imaging
Barci E, Mair MJ, Reis J, Müller K, Isakaj J, Istrefi E, von Polenz I, Siegmund SC, Kaiser L, Preusser M, Schichor C, Thon N, Harter P, von Baumgarten L, Forbrig R, Albert NL.   +15 more
europepmc   +1 more source

Differential isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 mutation-related landscape in intrahepatic cholangiocarcinoma. [PDF]

Oncologist
Xu S, Cao L, Chen R, Ye C, Li Q, Jiang Q, Yan F, Wan M, Zhang X, Ruan J.   +9 more
europepmc   +1 more source

<i>C. elegans</i> Cytoplasmic Isocitrate Dehydrogenase Neomorphic G98N and R133H Mutants Produce the Oncometabolite 2-Hydroxyglutarate. [PDF]

Int J Mol Sci
Bouchard M, McAllister A, Bourlett NS, Hoyt C, Calcul L, Walstrom KM.   +5 more
europepmc   +1 more source